162 related articles for article (PubMed ID: 1859886)
1. Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse.
Neale GA; Menarguez J; Kitchingman GR; Fitzgerald TJ; Koehler M; Mirro J; Goorha RM
Blood; 1991 Aug; 78(3):739-47. PubMed ID: 1859886
[TBL] [Abstract][Full Text] [Related]
2. Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia.
Dibenedetto SP; Lo Nigro L; Mayer SP; Rovera G; Schilirò G
Blood; 1997 Aug; 90(3):1226-32. PubMed ID: 9242556
[TBL] [Abstract][Full Text] [Related]
3. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
Chan DW; Liang R; Kwong YL; Chan V
Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
[TBL] [Abstract][Full Text] [Related]
4. Detection of T-cell receptor delta gene rearrangement by clonal specific polymerase chain reaction.
Chan DW; Liang R; Chan V; Kwong YL; Chan TK
Leukemia; 1997 Apr; 11 Suppl 3():281-4. PubMed ID: 9209365
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group.
Brisco MJ; Condon J; Hughes E; Neoh SH; Nicholson I; Sykes PJ; Tauro G; Ekert H; Waters K; Toogood I
Leukemia; 1993 Oct; 7(10):1514-20. PubMed ID: 8412313
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
Beishuizen A; Verhoeven MA; van Wering ER; Hählen K; Hooijkaas H; van Dongen JJ
Blood; 1994 Apr; 83(8):2238-47. PubMed ID: 8161789
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of minimal residual disease in childhood acute lymphoblastic leukemia patients by polymerase chain reaction analysis of multiple clone-specific or malignancy-specific gene markers.
Kuang S; Gu L; Dong S; Cao Q; Xu C; Huang W; Su XY; Huang QH; Xie JX; Chen SJ; Chen Z
Cancer Genet Cytogenet; 1996 Jun; 88(2):110-7. PubMed ID: 8640718
[TBL] [Abstract][Full Text] [Related]
8. PCR-heteroduplex analysis of TCR gamma, delta and TAL-1 deletions in T-acute lymphoblastic leukemias: implications in the detection of minimal residual disease.
Nirmala K; Rajalekshmy KR; Raman SG; Shanta V; Rajkumar T
Leuk Res; 2002 Apr; 26(4):335-43. PubMed ID: 11839375
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse.
Biondi A; Yokota S; Hansen-Hagge TE; Rossi V; Giudici G; Maglia O; Basso G; Tell C; Masera G; Bartram CR
Leukemia; 1992 Apr; 6(4):282-8. PubMed ID: 1316978
[TBL] [Abstract][Full Text] [Related]
10. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study.
Campana D; Yokota S; Coustan-Smith E; Hansen-Hagge TE; Janossy G; Bartram CR
Leukemia; 1990 Sep; 4(9):609-14. PubMed ID: 1975635
[TBL] [Abstract][Full Text] [Related]
11. Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia.
Kitchingman GR
Leukemia; 1994 Mar; 8(3):395-401. PubMed ID: 8127144
[TBL] [Abstract][Full Text] [Related]
12. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
[TBL] [Abstract][Full Text] [Related]
13. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients.
Yokota S; Hansen-Hagge TE; Ludwig WD; Reiter A; Raghavachar A; Kleihauer E; Bartram CR
Blood; 1991 Jan; 77(2):331-9. PubMed ID: 1824678
[TBL] [Abstract][Full Text] [Related]
14. Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia.
Neale GA; Pui CH; Mahmoud HH; Mirro J; Crist WM; Rivera GK; Goorha RM
Leukemia; 1994 May; 8(5):768-75. PubMed ID: 8182934
[TBL] [Abstract][Full Text] [Related]
15. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
[TBL] [Abstract][Full Text] [Related]
16. Detection of minimal residual disease in leukemic patients with the t(10;14)(q24;q11) chromosomal translocation.
Kagan J; Finger LR; Besa E; Croce CM
Cancer Res; 1990 Sep; 50(17):5240-4. PubMed ID: 2386934
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
[TBL] [Abstract][Full Text] [Related]
18. Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences.
Hansen-Hagge TE; Yokota S; Bartram CR
Blood; 1989 Oct; 74(5):1762-7. PubMed ID: 2676018
[TBL] [Abstract][Full Text] [Related]
19. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
Nakao M; Janssen JW; Flohr T; Bartram CR
Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia.
Scholten C; Födinger M; Mitterbauer M; Laczika K; Mitterbauer G; Haas OA; Knöbl P; Schwarzinger I; Thalhammer R; Purtscher B
Ann Hematol; 1995 Oct; 71(4):155-60. PubMed ID: 7578520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
